Transgenic mice overexpressing the Wnt inhibitor SFRP1 showed reduced scar formation and improved cardiac function following MI with significantly higher capillary density observed in transgenic hearts (Barandon et al., 2004, 2003). This evidence concerns the gene SFRP1 and myocardial infarction.